Ignite Creation Date:
2024-05-06 @ 4:21 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04968964
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2021-07-08
Brief Title:
Treatment Monitoring of Patients Receiving CDK 46 Inhibitors for Hormone Receptor HR Positive HER2 Negative Metastatic Breast Cancer MBC With or Without the Addition of DiviTum Serum Thymidine Kinase 1 TK1 Activity Testing
Sponsor:
Organization:
Washington University School of Medicine